It's that time again! Jim Cramer rang the lightning round bell, which means he gave his take on caller favorite stocks at rapid speed:
Procter & Gamble: "I like Procter. I'd like you to buy it a little bit cheaper, because I think it can come down to $84 or $85. But I think it's a good choice."
Synchrony Financial: "That thing has come down too much. That's kind of attractive to me ... You know what's more attractive? If Visa sells off a couple of bucks. My charitable trust owns it. I think that Charlie Scharf [outgoing CEO] has got some personal things he has to attend to at home in New York, and that stock is coming down and that may be a better opportunity."
Petrobras: "It has made a big comeback because the real has gotten very strong. Petrobras, I don't know. This is a play on the real, and the real is good but I think I don't want to overstay my welcome. I would be tempted to cash in on half."
Bristol-Myers Squibb: "Candidly, I was disappointed with the study that just came out. I thought that Opdivo had more opportunities to do it ... I do not expect anything good near-term for Bristol-Myers. That was just a disappointing study."
CIT Group: "Why don't you focus on Citi? My charitable trust owns Citi, that was the best quarter so far. I would be in Citi. JPMorgan was a great quarter, don't get me wrong. But they have done nothing but great quarters."
Radius Health: "Bob Ward [CEO], he has done a fantastic job, and I like Radius. Everyone keeps saying it's going to get a bid. I think it's going to have good test results, and therefore it is OK to own. But this whole bid thing is just getting out of control. I see this stock trading up a couple of bucks every morning, and I say come on."
Chesapeake Energy: "Chesapeake's got good natural gas exposure, but my problem is that I don't like the balance sheet. And because of that, there are so many others that are better. I think that you should just stock with Schlumberger. I think Schlumberger is the way to play the oil business."